Belgium Astellas Pharma B.V.
United States of America
製品と疾患領域
Rx+事業創成
アステラス製品の入手可能性の向上
事業活動におけるサステナビリティ
Pharmacovigilance
Adverse event reporting
Patient support services
Drug safety monitoring
Pharmaceutical development
Pharmaceutical research and development
Manufacturing of pharmaceutical products
Marketing and distribution of pharmaceutical products
製品
パイプライン
Bourne Business Park
Company name
Group
Parent
Subsidiary
Customer
Supplier
Alliance
Bank
Shareholder
Loading...
Loading the relationship graph...
2 entries
| Date | Description |
|---|
| 2005-04 |
Leaders from Yamanouchi and Fujisawa shake hands, marking the 2005 merger that formed Astellas and shaped a patient-first global strategy. Astellas was established in April 2005 through the merger of two companies – Yamanouchi Pharmaceutical (founded in 1923) and Fujisawa Pharmaceutical (founded in 1894). |
| 2025-04 |
In April 2025, Astellas celebrated our 20th Anniversary as a company. Astellas was established in April 2005 through the merger of two companies – Yamanouchi Pharmaceutical (founded in 1923) and Fujisawa Pharmaceutical (founded in 1894). The merger brought together Yamanouchi's strengths in urological medications and chemical synthesis and Fujisawa's excellence in the transplant/immunology area and fermentation technology, forming an ideal complementary partnership. |
2026-09-21 18:04 (Model: ggml-org/gpt-oss-20b )
